178 related articles for article (PubMed ID: 26418895)
21. SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas.
Koom WS; Kim TH; Shin KH; Pyo HR; Kim JY; Kim DY; Yoon M; Park SY; Lee DH; Ryu JS; Jung YS; Lee SH; Cho KH
Head Neck; 2008 Feb; 30(2):159-69. PubMed ID: 17764088
[TBL] [Abstract][Full Text] [Related]
22. A phase II trial of Endostar combined with gemcitabine and cisplatin chemotherapy in patients with metastatic nasopharyngeal carcinoma (NCT01612286).
Jin T; Li B; Chen XZ
Oncol Res; 2013; 21(6):317-23. PubMed ID: 25198661
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis.
Zhang SL; Han CB; Sun L; Huang LT; Ma JT
Radiat Oncol; 2020 Aug; 15(1):205. PubMed ID: 32831120
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma.
Imano N; Murakami Y; Nakashima T; Takeuchi Y; Takahashi I; Doi Y; Nishibuchi I; Kimura T; Wadasaki K; Ueda T; Hirakawa K; Nagata Y
Jpn J Radiol; 2017 Nov; 35(11):673-680. PubMed ID: 28887732
[TBL] [Abstract][Full Text] [Related]
25. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.
Lee SW; Back GM; Yi BY; Choi EK; Ahn SD; Shin SS; Kim JH; Kim SY; Lee BJ; Nam SY; Choi SH; Kim SB; Park JH; Lee KK; Park SH; Kim JH
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):152-60. PubMed ID: 16472934
[TBL] [Abstract][Full Text] [Related]
26. Recombined humanized endostatin (Endostar) intravenous infusion in the treatment of refractory nasopharyngeal carcinoma: Three case reports.
Chen C; Liu SR; Zhou S; Li XH; Wang XH; Tao YL; Chang H; Zhang WW; Li WF; Zhou SL; Xia YF
Medicine (Baltimore); 2019 Aug; 98(32):e16592. PubMed ID: 31393358
[TBL] [Abstract][Full Text] [Related]
27. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
Tham IW; Lin S; Pan J; Han L; Lu JJ; Wee J
Am J Clin Oncol; 2010 Jun; 33(3):294-9. PubMed ID: 20395788
[TBL] [Abstract][Full Text] [Related]
28. Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study.
Xu T; Liu Y; Dou S; Li F; Guan X; Zhu G
Oral Oncol; 2015 Sep; 51(9):875-9. PubMed ID: 26163437
[TBL] [Abstract][Full Text] [Related]
29. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
30. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy.
Chua DT; Sham JS; Leung LH; Au GK
Radiother Oncol; 2005 Dec; 77(3):290-4. PubMed ID: 16289398
[TBL] [Abstract][Full Text] [Related]
31. Concomitant chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma.
Cheng SH; Liu TW; Jian JJ; Tsai SY; Hao SP; Huang CH; Liu MC; Yu B; Huang AT
Cancer J Sci Am; 1997; 3(2):100-6. PubMed ID: 9099460
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of locoregionally advanced nasopharyngeal carcinoma treated with intensity modulated irradiation and platinum-based chemotherapy.
Xu JH; Guo WJ; Bian XH; Wu JF; Jiang XS; Guo YS; He X
Cancer Radiother; 2013; 17(4):297-303. PubMed ID: 23849438
[TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
34. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
35. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945
[TBL] [Abstract][Full Text] [Related]
36. Nasopharyngeal carcinoma treated with precision-oriented radiation therapy techniques including intensity-modulated radiotherapy: preliminary results.
Liu WS; Su MC; Wu MF; Tseng HC; Kuo HC
Kaohsiung J Med Sci; 2004 Feb; 20(2):49-55. PubMed ID: 15481551
[TBL] [Abstract][Full Text] [Related]
37. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.
Kwong DL; Sham JS; Leung LH; Cheng AC; Ng WM; Kwong PW; Lui WM; Yau CC; Wu PM; Wei W; Au G
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):374-81. PubMed ID: 16213105
[TBL] [Abstract][Full Text] [Related]
38. Weekly paclitaxel with concurrent radiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
Hu W; Ding W; Yang H; Shao M; Wang B; Wang J; Wu S; Wu S; Jin L; Ma CC
Radiother Oncol; 2009 Dec; 93(3):488-91. PubMed ID: 19679366
[TBL] [Abstract][Full Text] [Related]
39. Feasibility and efficacy study of weekly cisplatin with concurrent intensity-modulated radiation therapy for nasopharyngeal carcinoma: preliminary results.
Lu H; Chen J; Huang B; Cheng J; Peng L; Hao Y; Liao C; Mo Y; Wu D; Qin J
Oral Oncol; 2010 Oct; 46(10):743-7. PubMed ID: 20833579
[TBL] [Abstract][Full Text] [Related]
40. Intensity-modulated radiotherapy (IMRT)/Tomotherapy following neoadjuvant chemotherapy in stage IIB-IVA/B undifferentiated nasopharyngeal carcinomas (UCNT): a mono-institutional experience.
Franchin G; Vaccher E; Talamini R; Politi D; Gobitti C; Minatel E; Lleshi A; Sartor G; Mascarin M; Rumeileh IA; Trovò MG; Barzan L
Oral Oncol; 2011 Sep; 47(9):905-9. PubMed ID: 21783403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
